Related Experiment Video

Updated: Apr 29, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.3K

The effect of lycopene on the PI3K/Akt signalling pathway in prostate cancer

Jiezhong Chen, Adam O'Donoghue, Yi-Fu Deng

  • 1School of Biomedical Sciences, The University of Queensland, St Lucia, QLD 4072. j.chen4@uq.edu.au.

Anti-Cancer Agents in Medicinal Chemistry
|May 24, 2014
PubMed

Insights

Lycopene, found in tomatoes, shows promise in preventing and treating prostate cancer. This compound may work by affecting the PI3K/Akt pathway, offering a potential new avenue for cancer therapy.

Area of Science:

  • Oncology
  • Nutritional Science
  • Molecular Biology

Background:

  • Prostate cancer is a leading cause of cancer-related deaths in men.
  • Current treatments like androgen deprivation and chemotherapy have limitations, often leading to castration-resistant prostate cancer.
  • There is a critical need for novel and effective prostate cancer prevention and treatment strategies.

Purpose of the Study:

  • To review the potential of lycopene as a therapeutic agent for prostate cancer.
  • To summarize the mechanisms underlying lycopene's anti-cancer effects, particularly its impact on the PI3K/Akt pathway.

Main Methods:

  • Literature review focusing on studies investigating lycopene's role in prostate cancer.
  • Analysis of research detailing lycopene's effects on cellular pathways, including PI3K/Akt.

Main Results:

  • Lycopene, abundant in tomatoes and other fruits, demonstrates efficacy in both prostate cancer prevention and treatment.
  • Lycopene can achieve significantly higher concentrations in prostate tissue compared to other bodily tissues.
  • Evidence suggests lycopene influences the PI3K/Akt signaling pathway, a key regulator in cancer progression.

Conclusions:

  • Lycopene represents a promising natural compound for prostate cancer management.
  • Its ability to target the PI3K/Akt pathway offers a potential molecular mechanism for its anti-cancer properties.
  • Further research into lycopene could lead to improved therapeutic strategies for prostate cancer.

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.3K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.9K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K